The use of RWD data in place of placebo groups is improving various elements across the clinical trial space.

Sustainability-by-design in bioprocess development, according to Adam Goldstein, senior director of R&D Collaborations at ...

Robust project management is essential in any manufacturing business, particularly where strict regulations and complex production processes require maximum alignment between all involved ...

U.S. pharmaceutical companies are increasingly licensing new drugs from China. Former FDA Commissioner Scott Gottlieb ...

and partnerships between pharmaceutical companies and AI technology providers. By analyzing enormous volumes of biological and chemical data, AI algorithms and data analytic approaches are ...

Amit Chivate, senior market manager, Greater Asia and China, Roquette, provides his perspective on FDA’s recommendations ...

Dr Kaitin writes and speaks frequently on factors that contribute to the slow pace and high cost of pharmaceutical R&amp,D and the impact of efforts to speed the drug development process.

THE new Food and Drug Administration ... launch of the first pharmaceutical economic zone, Victoria Industrial Park. “We are on track; it is just a matter of time. We just have to follow normal ...

How CDMOs are reshaping pharmaceutical partnerships through friendshoring, risk-sharing economics, and specialized development capabilities.

When the Department of Health and Human Services (HHS) announced a new requirement for placebo testing on all new vaccines ...

The expiration of the FDA’s paediatric priority review voucher programme is creating uncertainty for rare disease drug ...